| Abstract |
A steering group has devised a protocol to compare relapse-free survival rates between women under 50 with stage II cancer, given CMF or Zoladex as adjuvant therapy. The design of the trial is discussed. |
| Authors | W Jonat |
| Journal | Hormone research
(Horm Res)
Vol. 32 Suppl 1
Pg. 223-5
( 1989)
ISSN: 0301-0163 [Print] Switzerland |
| PMID | 2533156
(Publication Type: Comparative Study, Journal Article)
|
| Chemical References |
- Goserelin
- Cyclophosphamide
- Buserelin
- Fluorouracil
- Methotrexate
|
| Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(drug therapy)
- Buserelin
(analogs & derivatives, therapeutic use)
- Cyclophosphamide
(therapeutic use)
- Female
- Fluorouracil
(therapeutic use)
- Goserelin
- Humans
- Methotrexate
(therapeutic use)
- Middle Aged
|
